OBAN Corporation has secured a one-year contract, valued at $1,711,759.28, from the Department of Health and Human Services’ Food and Drug Administration (FDA). The contract, awarded by the FDA Office of Acquisition Grant Services, is for the provision of Platform Communications and Training. This contract was awarded as an 8(a) Sole Source Definitive Contract.
Contract Details:
- Awardee Name: Oban Corporation
- Contract Duration: 12 months
- Total Contract Value: $1,711,759.28
- Funding Agency: Food and Drug Administration
- Funding Office: FDA Office of Acquisition Grant Services
- Number of Bidders: 1
- Set Aside Used: 8(a) Sole Source
- Award ID: 75F40124C00012
- Action Obligation: $1,711,759.28
- UEI: R3BFZ2VEZAT2
- Department Name: Department of Health and Human Services
- Start Date: December 6, 2023
- Ultimate Completion Date: December 5, 2024
- NAICS: 541611
- Contract Type: Labor Hours
- Award Type: Definitive Contract